FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

33 results

adempas
(riociguat)
Bayer HealthCare Pharmaceuticals Inc.
Usage: Adempas is indicated for adults with chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatment or if inoperable, as well as for pulmonary arterial hypertension (PAH). It improves exercise capacity, WHO functional class, and delays clinical worsening. The drug is effective as monotherapy or in combination with other treatments.
asclera
(POLIDOCANOL)
Methapharm, Inc
Usage: Asclera® (polidocanol) is indicated for the sclerotherapy of uncomplicated spider veins (≤1 mm) and reticular veins (1 to 3 mm) in the lower extremities. It is not approved for use in varicose veins greater than 3 mm in diameter.
atorvaliq
(ATORVALIQ)
CMP Pharma, Inc.
Usage: ATORVALIQ is indicated to reduce the risk of cardiovascular events in adults with risk factors for coronary heart disease, type 2 diabetes, and clinically evident coronary heart disease. It also lowers LDL cholesterol in various conditions, including primary hyperlipidemia and familial hypercholesterolemia, as an adjunct to diet or other therapies.
benicar
(olmesartan medoxomil)
Cosette Pharmaceuticals, Inc.
Usage: Benicar is indicated for treating hypertension in adults and children aged six and older to lower blood pressure, reducing the risk of cardiovascular events like strokes and heart attacks. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.
benicar hct
(olmesartan medoxomil-hydrochlorothiazide)
Cosette Pharmaceuticals, Inc.
Usage: BENICAR HCT (olmesartan medoxomil and hydrochlorothiazide) is indicated for the treatment of hypertension to lower blood pressure. It is not intended for initial therapy and may be used alone or with other antihypertensive medications to reduce cardiovascular risk, including strokes and myocardial infarctions.
caduet
(amlodipine besylate and atorvastatin calcium)
Pfizer Laboratories Div Pfizer Inc
Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.
cleviprex
(clevipidine)
Chiesi USA, Inc.
Usage: Cleviprex is indicated for lowering blood pressure in situations where oral medication is not feasible or desirable.
corlanor
(ivabradine)
Amgen Inc
Usage: Corlanor is indicated to reduce hospitalization risk for adults with stable, symptomatic chronic heart failure (left ventricular ejection fraction ≤ 35%) and resting heart rate ≥ 70 bpm. It is also used for pediatric patients aged 6 months and older with stable symptomatic heart failure due to dilated cardiomyopathy.
eliquis
(apixaban)
E.R. Squibb & Sons, L.L.C.
Usage: ELIQUIS is indicated to reduce the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, as well as for the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It also reduces the risk of recurrence of DVT and PE post-therapy.
entresto
(Sacubitril and Valsartan)
Novartis Pharmaceuticals Corporation
Usage: ENTRESTO is indicated for reducing cardiovascular death and hospitalization in adults with chronic heart failure, particularly those with reduced left ventricular ejection fraction. It is also used to treat symptomatic heart failure in pediatric patients aged one year and older, aiming to improve cardiovascular outcomes.

Cardiology & Vascular drugs

adempas

asclera

atorvaliq

benicar

benicar hct

caduet

cleviprex

corlanor

eliquis

entresto